Global Health Limited announced its financial results for the Second Quarter and Half Year ended September 30, 2026. The company reported a significant 34% year-on-year revenue growth, primarily driven by an increase in patient volumes. The presentation also highlighted capacity expansion initiatives, a robust project pipeline, and capital expenditure plans aimed at driving sustainable growth.
Global Health Limited Q2 FY2027 Performance Update
Global Health Limited has released its investor presentation detailing the financial and operational performance for the Second Quarter and Half Year ended September 30, 2026. The company showcased a strong revenue growth of 34% year-on-year, largely attributed to an expansion in patient volumes across its network. This growth underscores the company’s operational momentum and market position.
Key Financial Highlights
For the second quarter of FY2027, revenue from operations reached INR 14,690 million, marking a 33.6% increase compared to the same period last year. Operating EBITDA saw a substantial jump of 60.2% year-on-year to INR 3,701 million, with margins improving to 25.2% from 21.0%. Profit After Tax (PAT) grew by 38.3% to INR 2,191 million, with PAT margins at 14.9%.
The first half of FY2027 also demonstrated robust performance, with revenue from operations increasing by 30.2% to INR 27,731 million. Operating EBITDA grew by 43.4% to INR 6,568 million, and PAT rose by 18.6% to INR 3,764 million.
Operational and Capacity Expansion
The presentation highlighted significant capacity expansion projects. During Q2 FY2027, 74 new beds were added across the network, with 49 beds in Noida and 25 in Lucknow, bringing the total bed capacity to 3,115. Occupied bed days increased by 22.4% year-on-year, achieving an occupancy rate of approximately 67%. Average revenue per patient (ARPP) for the quarter stood at INR 2.06 lakh, a 2.7% increase year-on-year.
Cluster 1 hospitals (Gurugram, Indore, Ranchi) reported revenue growth of 17.8% and an operating EBITDA margin expansion to 22.0%. Cluster 2 hospitals (Lucknow, Patna, Noida) experienced even stronger growth with revenue up 63.2% and operating EBITDA increasing by 110.0%, pushing margins to 31.7%.
Capex and Future Outlook
Global Health Limited has planned a total capex of approximately INR 62,390 million over the next 4-5 years. This includes significant investments in new projects across various cities such as Lucknow, South Delhi, Pitampura, Mumbai, Guwahati, Varanasi, and Indore, alongside maintenance capex. The company’s strategy focuses on expanding its footprint and enhancing its service offerings to drive sustainable growth and maintain its position as a leader in healthcare.
Medanta’s Mission and Model
The presentation also touched upon Medanta’s founding philosophy of providing world-class, patient-centric healthcare. The company’s model emphasizes exceptional clinical talent, world-class infrastructure, advanced technology, and compassionate care. Its mission is to deliver integrated and affordable healthcare while fostering the development of people and knowledge, guided by core values of patient centricity, leadership, integrity, and collaboration.
Source: BSE
